As the global economy mends, the 2021 growth of Oral Drug Delivery will have significant change from previous year. According to our (LP Information) latest study, the global Oral Drug Delivery market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Oral Drug Delivery market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Oral Drug Delivery market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Drug Delivery market, reaching US$ million by the year 2028. As for the Europe Oral Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oral Drug Delivery players cover AstraZeneca Plc., Mylan N.V., Sanofi, and F. Hoffman-La-Roche Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Diffusion Controlled Release System
Dissolution Controlled Release System
Ion Exchange Resins Controlled Release
Hydro-dynamically Balanced Drug Delivery System
Osmotically Controlled Release System
Dissolution & Diffusion Controlled Release System
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AstraZeneca Plc.
Mylan N.V.
Sanofi
F. Hoffman-La-Roche Ltd.
Bristol-Myers Squibb Company
Sun Pharmaceuticals Industries Ltd
Abbott Laboratories
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Vectura Group plc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc